全文获取类型
收费全文 | 4782篇 |
免费 | 305篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 113篇 |
儿科学 | 76篇 |
妇产科学 | 70篇 |
基础医学 | 615篇 |
口腔科学 | 60篇 |
临床医学 | 482篇 |
内科学 | 1088篇 |
皮肤病学 | 181篇 |
神经病学 | 516篇 |
特种医学 | 163篇 |
外科学 | 505篇 |
综合类 | 22篇 |
一般理论 | 1篇 |
预防医学 | 361篇 |
眼科学 | 76篇 |
药学 | 339篇 |
中国医学 | 3篇 |
肿瘤学 | 418篇 |
出版年
2023年 | 33篇 |
2022年 | 62篇 |
2021年 | 141篇 |
2020年 | 102篇 |
2019年 | 146篇 |
2018年 | 137篇 |
2017年 | 103篇 |
2016年 | 116篇 |
2015年 | 120篇 |
2014年 | 189篇 |
2013年 | 243篇 |
2012年 | 347篇 |
2011年 | 344篇 |
2010年 | 192篇 |
2009年 | 151篇 |
2008年 | 269篇 |
2007年 | 270篇 |
2006年 | 270篇 |
2005年 | 253篇 |
2004年 | 220篇 |
2003年 | 175篇 |
2002年 | 159篇 |
2001年 | 78篇 |
2000年 | 74篇 |
1999年 | 68篇 |
1998年 | 33篇 |
1997年 | 33篇 |
1996年 | 36篇 |
1995年 | 48篇 |
1994年 | 24篇 |
1993年 | 27篇 |
1992年 | 49篇 |
1991年 | 52篇 |
1990年 | 40篇 |
1989年 | 43篇 |
1988年 | 46篇 |
1987年 | 33篇 |
1986年 | 22篇 |
1985年 | 27篇 |
1984年 | 33篇 |
1983年 | 28篇 |
1982年 | 34篇 |
1981年 | 20篇 |
1979年 | 24篇 |
1978年 | 15篇 |
1977年 | 16篇 |
1975年 | 15篇 |
1974年 | 20篇 |
1972年 | 18篇 |
1970年 | 12篇 |
排序方式: 共有5089条查询结果,搜索用时 15 毫秒
31.
Detection and typing of human papillomavirus using the Vira Type "in situ" kit: comparison with a conventional dot blot technique 下载免费PDF全文
B E Faulkner-Jones V M Bellomarino A J Borg K Orzeszko S M Garland 《Journal of clinical pathology》1990,43(11):913-917
A new commercial kit (Vira Type "in situ", Life Technologies, Inc., Molecular Diagnostics Division, Guithersburg, Maryland, USA) for the detection of human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33 and 35 in routinely processed human anogenital tissue was compared with a conventional dot blot assay for HPV 6, 11, 16 and 18. Both systems use double-stranded genomic DNA probes for the detection of type specific HPV DNA. The probes used on the dot blots were labelled with 32P and visualised autoradiographically. The Vira Type probes were labelled with biotin and visualised using a streptavidin-alkaline phosphatase conjugate with NBT-BCIP substrate. Biopsy specimens from the cervix, vagina, and vulva of 46 women were processed by both methods and compared. The histological diagnoses ranged from benign changes, to dysplasia, and invasive carcinoma. Overall, 50% of biopsy specimens were positive for HPV DNA by dot blot hybridisation; only 39% were positive by Vira Type in situ hybridisation. Three of the specimens positive by the Vira Type "in situ" kit showed no cross hybridisation and were the same HPV type as the dot blot. A further 13 showed hybridisation, but the showed cross hybridisation, but the to the dot blot results. One biopsy specimen was positive for different HPV types by the two tests and one was positive by Vira Type and negative by dot blot. Six biopsy specimens were negative by Vira Type but positive by dot blot. It is concluded that the Vira Type "in situ" kit has a similar specificity but lower sensitivity than the dot blot hybridisation method for the detection of HPV DNA. 相似文献
32.
Germ-line mutations in the p16/CDKN2 gene are known to predispose to melanoma. This gene belongs to a family of cyclin-dependent kinase inhibitors and blocks G1-S progression. The occurrence of p16/CDKN2 germline mutations in 12 Icelandic melanoma kindreds (kindreds with two or more cases of melanoma or melanoma, pancreas and/or glioma cases) was examined. No germ-line mutation was found, however five mutations not previously discribed in solid tumours were identified, Pro48Leu, Ala57Val, Gly89Asp, Leu117Met, Tyr129Stop. 相似文献
33.
Rohde M Daugaard M Jensen MH Helin K Nylandsted J Jäättelä M 《Genes & development》2005,19(5):570-582
Whereas the stress-inducible heat-shock protein 70 (Hsp70) has gained plenty of attention as a putative target for tumor therapy, little is known about the role of other Hsp70 proteins in cancer. Here we present the first thorough analysis of the expression and function of the cytosolic Hsp70 proteins in human cancer cells and identify Hsp70-2, a protein essential for spermatogenesis, as an important regulator of cancer cell growth. Targeted knock-down of the individual family members by RNA interference revealed that both Hsp70 and Hsp70-2 were required for cancer cell growth, whereas the survival of tumorigenic as well as nontumorigenic cells depended on Hsc70. Cancer cells depleted for Hsp70 and Hsp70-2 displayed strikingly different morphologies (detached and round vs. flat senescent-like), cell cycle distributions (G2/M vs. G1 arrest) and gene expression profiles. Only Hsp70-2 depletion induced the expression of macrophage inhibitory cytokine-1 that was identified as a target of P53 tumor-suppressor protein and a mediator of the G1 arrest and the senescent phenotype. Importantly, concomitant depletion of Hsp70 and Hsp70-2 had a synergistic antiproliferative effect on cancer cells. Thus, highly homologous Hsp70 proteins bring about nonoverlapping functions essential for cell growth and survival. 相似文献
34.
35.
36.
We investigated the accuracy of total body mineral (TBBM) measured by dual photon absorptiometry (1 Ci 153Gd source, 44 and 100 KeV) using skeletons, soft tissue equivalent materials and whole cadaver extremities. The accuracy was assessed on five skeletons (r = 0.99, SEE = 1.5%). The influence of the soft tissue composition on the TBBM measurement was investigated in the same five skeletons. They were scanned in a 16 cm thickness of ethanol solutions of different concentration (0, 20, 40, 60, 80, 100% ethanol) and only a 2% difference (non-significant) was found between measuring 100% ethanol and 100% water. Furthermore, seven whole cadaver extremities were scanned before and after removal of the soft tissues (r = 0.995, SEE = 6.3%). The slope was not different from one and the intercept not different from zero. Equipment at the University of Wisconsin, Madison, and at Glostrup Hospital, Denmark, was compared by measuring the same healthy subjects and skeletons on both scanners. The Glostrup and Madison TBBM values correlated well (r = 0.99, SEE = 5.8%) and the intercept (345 Glostrup arbitrary units) was not significantly different from zero (P greater than 0.05). The TBBM results were calibrated into total body calcium (TBCa) and no significant difference was found between Glostrup and Madison TBCa values (P greater than 0.20). 相似文献
37.
Escudier B Dorval T Chaput N André F Caby MP Novault S Flament C Leboulaire C Borg C Amigorena S Boccaccio C Bonnerot C Dhellin O Movassagh M Piperno S Robert C Serra V Valente N Le Pecq JB Spatz A Lantz O Tursz T Angevin E Zitvogel L 《Journal of translational medicine》2005,3(1):10-13
BACKGROUND: DC derived-exosomes are nanomeric vesicles harboring functional MHC/peptide complexes capable of promoting T cell immune responses and tumor rejection. Here we report the feasability and safety of the first Phase I clinical trial using autologous exosomes pulsed with MAGE 3 peptides for the immunization of stage III/IV melanoma patients. Secondary endpoints were the monitoring of T cell responses and the clinical outcome. PATIENTS AND METHODS: Exosomes were purified from day 7 autologous monocyte derived-DC cultures. Fifteen patients fullfilling the inclusion criteria (stage IIIB and IV, HLA-A1+, or -B35+ and HLA-DPO4+ leukocyte phenotype, tumor expressing MAGE3 antigen) were enrolled from 2000 to 2002 and received four exosome vaccinations. Two dose levels of either MHC class II molecules (0.13 versus 0.40 x 1014 molecules) or peptides (10 versus 100 mug/ml) were tested. Evaluations were performed before and 2 weeks after immunization. A continuation treatment was performed in 4 cases of non progression. RESULTS: The GMP process allowed to harvest about 5 x 1014 exosomal MHC class II molecules allowing inclusion of all 15 patients. There was no grade II toxicity and the maximal tolerated dose was not achieved. One patient exhibited a partial response according to the RECIST criteria. This HLA-B35+/A2+ patient vaccinated with A1/B35 defined CTL epitopes developed halo of depigmentation around naevi, a MART1-specific HLA-A2 restricted T cell response in the tumor bed associated with progressive loss of HLA-A2 and HLA-BC molecules on tumor cells during therapy with exosomes. In addition, one minor, two stable and one mixed responses were observed in skin and lymph node sites. MAGE3 specific CD4+ and CD8+ T cell responses could not be detected in peripheral blood. CONCLUSION: The first exosome Phase I trial highlighted the feasibility of large scale exosome production and the safety of exosome administration. 相似文献
38.
Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families 总被引:5,自引:0,他引:5
39.
Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus. 总被引:2,自引:1,他引:2 下载免费PDF全文
E J ter Borg G Horst P C Limburg C G Kallenberg 《Clinical and experimental immunology》1990,82(1):21-26
Interleukin-2 receptor (IL-2R) is expressed and released predominantly by activated T cells. In order to investigate whether disease exacerbations of systemic lupus erythematosus (SLE) are preceded by T cell activation, we prospectively measured levels of IL-2R once a month, from 6 months prior to exacerbations until 1 month afterwards. To assess the temporal relation between T cell activation and B cell activation, we measured, in addition, levels of anti-dsDNA, complement C3/C4, and total IgG. During a mean follow-up period of 23 months, 40 exacerbations occurred in 21 out of the 71 participating patients. For the present study one exacerbation per patient was evaluated. During exacerbation levels of IL-2R were increased in 18 out of the 21 cases and correlated with levels of anti-dsDNA (P less than 0.02), C3 (P less than 0.02), and C4 (P less than 0.01), but not with the score of the disease activity index. Levels of IL-2R rose prior to the exacerbation (P less than 0.02) and fell afterwards following treatment (P less than 0.05). Even in the absence of disease activity or during minor disease symptoms IL-2R levels were higher (P less than 0.01) than in healthy controls. Sixteen out of the 21 exacerbations (76%) were preceded by a significant increase in IL-2R. Changes in levels of anti-dsDNA and complement C3/C4 tended to precede changes in levels of IL-2R. We conclude that increased levels of IL-2R, compatible with T cell activation, are present in SLE already during inactive disease. These levels further increased prior to exacerbations of disease. As such, IL-2R is an indicator of disease activity in SLE. Serial measurement of IL-2R is a sensitive test for predicting disease exacerbations of SLE. 相似文献
40.
Jacqueline Schoumans Johan Staaf Gran Jnsson Johanna Rantala Kerstin Sars Zimmer ke Borg Magnus Nordenskjld Britt-Marie Anderlid 《European journal of medical genetics》2005,48(3):290-CGH
Smith–Magenis syndrome (SMS) is a multiple congenital anomaly/mental retardation syndrome and it is characterized by an interstitial deletion of chromosome 17p11.2. SMS patients have a distinct phenotype which is believed to be caused by haploinsufficiency of one or more genes in the associated deleted region. Five non-deletion patients with classical phenotypic features of SMS have been reported with mutations in the retinoic acid induced 1 (RAI1) gene, located within the SMS critical interval. Happloinsufficiency of the RAI1 gene is likely to be the responsible gene for the majority of the SMS features, but other deleted genes in the SMS region may modify the overall phenotype in the patients with 17p11.2 deletions. SMS is usually diagnosed in the clinical genetic setting by FISH analysis using commercially available probes. We detected a submicroscopic deletion in 17p11.2 using array-CGH with a resolution of approximately 1 Mb in a patient with the SMS phenotype, who was not deleted for the commercially available SMS microdeletion FISH probe. Delineation of the deletion was performed using a 32K tiling BAC-array, containing 32,500 BAC clones. The deletion in this patient was size mapped to 2.7 Mb and covered the RAI1 gene. This case enabled the refinement of the SMS minimum deletion to 650 kb containing eight putative genes and one predicted gene. In addition, it demonstrates the importance to investigate deletion of RAI1 in SMS patients. 相似文献